Sanofi/Regeneron’s Esophagitis Data Add To Dupixent’s Winning Streak

Sanofi and Regeneron announced results from a Phase III trial of Dupixent in eosinophilic esophagitis • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapeutic Category